11/20/2024
7:23 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:57 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:14 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/19/2024
8:20 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/15/2024
4:22 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:25 PM | Diep Tuan Tu (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/15/2024
4:28 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
11/15/2024
4:31 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/14/2024
9:02 AM | JANUS HENDERSON GROUP PLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13G/A | |
11/14/2024
8:21 AM | Altium Capital Management LP (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13G/A | |
10/30/2024
7:25 PM | Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:25 PM | Charych Deborah H. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:28 PM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:29 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:30 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:31 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:32 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
7:33 PM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/29/2024
4:25 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/24/2024
3:59 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/23/2024
4:25 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form DEF 14A | |
09/13/2024
5:54 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:56 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:18 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form PRE 14A | |
09/04/2024
5:12 PM | Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
4:25 PM | Arora Puneet S. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
08/27/2024
4:20 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
4:18 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
4:29 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
07/05/2024
7:58 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
07/05/2024
7:59 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Smith Karen L. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/03/2024
6:05 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/10/2024
8:27 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/19/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
05/19/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
04/28/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
04/24/2024
3:40 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form POS AM | |
04/10/2024
11:15 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form EFFECT | |
04/10/2024
3:40 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 424B3 | |
04/10/2024
8:58 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form CERT | |
04/10/2024
6:00 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-A12B | |
Do this Before Elon’s Reveal on January 22nd (Ad) Elon’s newest tech could pay you an extra $30,000 a year — while you sleep.
It’s smaller than a quarter but designed to power a $9 trillion AI revolution.
And I’ve identified a little-known supplier Elon is depending on to make it all happen. I urge you to watch this video now. |
04/04/2024
4:32 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-1/A | |
03/27/2024
4:27 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
03/21/2024
7:41 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/15/2024
3:15 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
6:28 PM | 5AM Partners VII, LLC (Filed by)
Skye Bioscience (Subject)
Skye Bioscience (Subject)
| Form SC 13D/A | |
03/13/2024
3:13 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
6:53 PM | Grayson Paul A. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:23 PM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:18 PM | Jenkins Annalisa (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
5:13 AM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4/A | |
03/04/2024
5:15 AM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4/A | |
03/04/2024
5:17 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
03/04/2024
5:19 AM | Diep Tuan Tu (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:20 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
TYLE PRAVEEN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:23 AM | Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Ward Keith Wayne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:24 AM | DALESANDRO MARGARET (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:24 PM | DHILLON PUNIT (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2024
5:42 PM | ARSENAULT KAITLYN (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/12/2024
11:08 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form D
Notice of Exempt Offering of Securities | |
02/08/2024
8:51 AM | Skye Bioscience (Subject)
Skye Bioscience (Subject)
SPHERA FUNDS MANAGEMENT LTD. (Filed by)
| Form SC 13G | |
02/02/2024
3:32 PM | 5AM CO-INVESTORS II LP (Reporting)
5AM CO-INVESTORS II LP (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners II, LLC (Reporting)
5AM Partners VII, LLC (Reporting)
5AM Ventures II LP (Reporting)
5AM Ventures VII, L.P. (Reporting)
DIEKMAN JOHN D (Reporting)
DIEKMAN JOHN D (Reporting)
PARMAR KUSH (Reporting)
PARMAR KUSH (Reporting)
ROCKLAGE SCOTT M (Reporting)
ROCKLAGE SCOTT M (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:35 PM | Schwab Andrew J. (Reporting)
Skye Bioscience (Issuer)
Skye Bioscience (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
7:02 AM | Skye Bioscience (Filer)
Skye Bioscience (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
